MLXIPL and Insulin resistance: The precise mechanism of driving DNL in MASLD is still unknown, but under the background of systemic insulin resistance, due to the increase of circulating insulin and glucose, the activation of two main transcription factors, SREBP-1c and carbohydrate-responsive element binding protein (ChREBP), has been considered a core driving factor (43).